Nkarta logo

Nkarta share price today

(NKTX)

Nkarta share price is $2.46 & ₹211.09 as on 7 Jan 2025, 2.30 'hrs' IST

$2.46

-0.04

(-1.6%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Nkarta share price in Dollar and Rupees. Guide to invest in Nkarta stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Nkarta, along with analyst recommendations, forecasts, and comprehensive financials.

Nkarta share price movements

  • Today's Low: $2.42
    Today's High: $2.53

    Day's Volatility :4.2%

  • 52 Weeks Low: $2.08
    52 Weeks High: $16.24

    52 Weeks Volatility :87.19%

Nkarta Returns

PeriodNkarta IncSector (Health Care)Index (Russel 2000)
3 Months
-35.9%
-8.4%
0.0%
6 Months
-56.29%
-3.8%
0.0%
1 Year
-76.7%
-0.1%
0.0%
3 Years
-81.63%
2.9%
-19.8%

Nkarta Key Statistics

in dollars & INR

Previous Close
$2.5
Open
$2.55
Today's High
$2.5285
Today's Low
$2.4223
Market Capitalization
$175.7M
Today's Volume
$1.1M
52 Week High
$16.24
52 Week Low
$2.08
Revenue TTM
$385.0
EBITDA
$-118.1M
Earnings Per Share (EPS)
$-1.83
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-30.4%

How to invest in Nkarta from India?

It is very easy for Indian residents to invest directly in Nkarta from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Nkarta stock in both Indian Rupees (INR) and US Dollars (USD). Search for Nkarta or NKTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Nkarta or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Nkarta shares which would translate to 0.349 fractional shares of Nkarta as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Nkarta, in just a few clicks!

Returns in Nkarta for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Nkarta investment value today

Current value as on today

₹26,149

Returns

₹73,851

(-73.85%)

Returns from Nkarta Stock

₹77,074 (-77.07%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Nkarta

-53%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Nkarta on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -53% less investors are searching Nkarta in the last 30 days versus the previous period.

Global Institutional Holdings in Nkarta

  • RA Capital Management, LLC

    15.31%

  • COMMODORE CAPITAL LP

    6.61%

  • BlackRock Inc

    5.75%

  • Boxer Capital LLC

    5.71%

  • Samsara BioCapital, LLC

    5.34%

  • Adage Capital Partners Gp LLC

    5.10%

Analyst Recommendation on Nkarta

Buy

    93%Buy

    6%Hold

    0%Sell

Based on 16 Wall street analysts offering stock ratings for Nkarta(by analysts ranked 0 to 5 stars)

Based on 16 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
15
15
15
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Nkarta

What analysts predicted

Upside of 543.63%

Current:

$2.46

Target:

$15.83

Insights on Nkarta

  • Price Movement

    In the last 3 months, NKTX stock has moved down by -36.2%
  • NKTX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 82.4%
  • NKTX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 136.6%

Nkarta Technicals Summary

Sell

Neutral

Buy

Nkarta is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Nkarta Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Nkarta Inc
1.21%
-56.29%
-76.7%
-81.63%
-94.78%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Nkarta Inc
NA
NA
NA
-1.67
-0.3
-0.17
NA
6.11
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Nkarta Inc
Buy
$175.7M
-94.78%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Nkarta

nkarta therapeutics seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies. nkarta was founded on the proprietary, robust and well characterized natural killer (nk) cell expansion technology pioneered by dario campana. the company is focused on leveraging the natural potent power of nk cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. nkarta is combining its nk expansion platform technology with proprietary cell engineering technologies to build differentiated autologous and allogeneic cell therapy candidates for the treatment of cancer. founded in 2015, the company’s investors include sr one, nea and novo ventures. for more information, please visit the company’s website at www.nkartatx.com.
Organization
Nkarta
Employees
159
CEO
Mr. Paul J. Hastings
Industry
Health Technology

Management People of Nkarta

NameTitle
Mr. Paul J. Hastings
CEO & Director
Ms. Alyssa Levin C.A., CPA
Chief Financial & Business Officer and Principal Accounting Officer
Dr. David R. Shook M.D.
Chief Medical Officer & Head of Research and Development
Dr. Nadir Mahmood Ph.D.
President
Dr. Ralph Brandenberger Ph.D.
Chief Technical Officer
Mr. Greg Mann
Vice President of Public Affairs and Investor Relations
Dr. Alicia J. Hager
Chief Legal Officer & Corporate Secretary

Important FAQs about investing in Nkarta from India :

What is Nkarta share price today?

Nkarta share price today stands at $2.46, Open: $2.55 ; Previous Close: $2.50 ; High: $2.53 ; Low: $2.42 ; 52 Week High: $16.24 ; 52 Week Low: $2.08. The stock opens at $2.55, after a previous close of $2.50. The stock reached a daily high of $2.53 and a low of $2.42, with a 52-week high of $16.24 and a 52-week low of $2.08.

Can Indians buy Nkarta shares?

Yes, Indians can invest in the Nkarta (NKTX) from India.

With INDmoney, you can buy Nkarta at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Nkarta at zero transaction cost.

How can I buy Nkarta shares from India?

It is very easy to buy Nkarta from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Nkarta be purchased?

Yes, you can buy fractional shares of Nkarta with INDmoney app.

What are the documents required to start investing in Nkarta stocks?

To start investing in Nkarta, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Nkarta

Today’s highest price of Nkarta (NKTX) is $2.53.

Today’s lowest price of Nkarta (NKTX) is $2.42.

What is today's market capitalisation of Nkarta

Today's market capitalisation of Nkarta NKTX is 175.7M

What is the 52 Week High and Low Range of Nkarta

  • 52 Week High

    $16.24

  • 52 Week Low

    $2.08

What are the historical returns of Nkarta?

  • 1 Month Returns

    1.21%

  • 3 Months Returns

    -56.29%

  • 1 Year Returns

    -76.7%

  • 5 Years Returns

    -94.78%

Who is the Chief Executive Officer (CEO) of Nkarta

Mr. Paul J. Hastings is the current Chief Executive Officer (CEO) of Nkarta.